5.5% Health Care Protect Reverse Convertible Bond – available on secondary market

5.5% Health Care Protect Reverse Convertible Bond – available on secondary market

2 year term, fixed annual interest rate of 5.5% and barrier being set at 59% of each share

The 5.5% Health Care Protect Reverse Convertible Bond combines twofixed interest payments of 5.5% with a partial safety mechanism for the invested capital down to the barrier. The interest amount is paid out annually, regardless of the performance of the three underlying shares (Bayer AG, Fresenius SE & Co. KGaA., Koninklijke Philips N.V.).

The share basket of the Protect Reverse Convertible Bond consists of three heavyweights of the health care sector:

  • The life science group Bayer AG operates in the chemical and pharmaceutical industry. The company‘s core competencies lie in the fields of health care and agriculture.
     
  • The German health care group Fresenius SE & Co. KGaA, an international dialysis specialist, supplies hospitals with medical equipment and provides patients with transfusions.
     
  • The Dutch group Koninklijke Philips N.V. counts among the leading providers of technology in the health care sector. The company covers all stages of the health care cycle: prevention, diagnostics, therapy and care.

The certificate is redeemed at 100% of the nominal value at the maturity date (June 2020), provided that the daily closing price of each of the three underlying shares always quotes above the respective barrier of 59% during the observation period (daily observation).

If one of the barriers is touched or undercut by the daily closing price of at least one of the underlying shares and at least one of these shares closes below its strike at the final valuation date, the predefined amount of the worst performing share is delivered (percentage performance from the starting value to the closing price at the final valuation date).

Further information as well as the Key Information Document please find on Product Page.

For any additional information you may require do not hesitate to contact us on +43151520484.

The Structured Products Team of Raiffeisen Centrobank



The product described herein is subject to and governed by the Base Prospectus (including all supplements and amendments thereto) approved by the Austrian Financial Market Authority (FMA). The Base Prospectus has been deposited at the Oesterreichische Kontrollbank AG, published at www.rcb.at/securitiesprospectus and contains the risks and terms and conditions of the product.

Additional information may also be obtained from the key information document of the product published at www.rcb.at. Raiffeisen Centrobank AG is subject to supervision by the FMA and the Austrian National Bank as well as the European Central Bank within the Single Supervisory Mechanism (Council Regulation (EU) No 1024/2013).

Key facts:
  • ISIN: AT0000A21GE0
  • Initial valuation date: Jun 27, 2018
  • Term: 2 years
    (Maturity date: Jun 30, 2020)
  • Listing: Vienna, Frankfurt, Stuttgart
Contact
The Structured Products Team
T: +43151520484
F: +431 513 43 96
E: produkte(at)rcb.at